Press Conference Will Report Significant Clinical Findings for Treatment of Breast Cancer

Thursday, October 09, 2003

VIDEO ALERT: B-roll and sound bites from the subject expert will be fed on Thursday, Oct. 9. Please see the end of this release for details.

Oct. 7, 2003

Mary Lawson
John Murphy
507- 284-5005 (days)
507-284-2511 (evenings)
e-mail: newsbureau@mayo.edu

EMBARGOED: Hold for release until Thursday, Oct. 9, 2003, at 10:30 a.m. CDT

MEDIA ADVISORY

Press Conference Will Report Significant Clinical Findings for Treatment of Breast Cancer

What: A significant advance has emerged from a large international phase III clinical trial that will expand current treatments for breast cancer and provide survivors with greater hope for long-term survival. Thousands of breast-cancer survivors from throughout the world participated in the clinical study. Because of the positive results, the study has been halted to provide information to breast-cancer survivors, their physicians and the public.

Who: James Ingle, M.D., a Mayo Clinic medical oncologist, led the research study in the United States.

The clinical study was led internationally by a Canadian researcher. In addition to Dr. Ingle, researchers from the Canadian Cancer Society, Princess Margaret Hospital (Toronto, Ontario), U.S. National Cancer Institute and the National Cancer Institute of Canada Clinic Trial Group at QueenÕs University (Kingston, Ontario) will speak at the press conference.

When: The press conference will be held Thursday, Oct. 9, at 10:30 a.m. CDT.

Where: Ballroom A, Intercontinental Hotel (formerly the Crowne Plaza Hotel)
225 Front St. West
Toronto, Ontario

Webcast: The press conference also can be accessed via the Web in both RealMedia and WindowsMedia technology at http://webevents.broadcast.com/cnw/CC20031009. Registered media will have an opportunity to ask questions after the presentations.

Notes: For interviews with Dr. Ingle, call 507-284-5005. All spokespeople will be available for interviews after the press conference. For those interviews, call 416-597-8189. The package includes soundbites from Dr. Ingle, a breast cancer survivor participating in the study and the Canadian researcher; b-roll of Mayo Clinic, researchers and a patient, and script to use for preparing the story.

Please see next page for satellite coordinates for the b-roll and soundbites.

###
- 2 -
TECHNICAL INFORMATION

Thursday, Oct. 9, 2003
Breast cancer study

Eastern / Central
Test: 11:30-11:35 EDT / 10:30-10:35 CDT
Program: 11:35-12:00 / 10:35-11:00

Satellite Coordinates
Ku-Band / C-Band
Satellite: Galaxy 11 / Galaxy 4R
Transponder: 14 (V) / 20 (V)
Channel: 14 / 20
Downlink Frequency: 11980.0 MHz / 4100.0 MHz
Audio: 6.2 or 6.8 MHz / 6.2 or 6.8 MHz
Longitude: 91¡ W / 99¡ W

For news release information, please contact: 507-284-5005 (Mayo Clinic Communications) For satellite technical questions or difficulties, contact: (800) 608-3663 (Strategic Television) or (507) 284-9118 (Mayo Clinic Satellite Desk)

###

To obtain the latest news releases from Mayo Clinic, go to www.mayoclinic.org/news. MayoClinic.com is available as a resource for your health stories.